Squarepoint Ops LLC Exact Sciences Corp Call Options Transaction History

Squarepoint Ops LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$42.43 - $70.83 $560,076 - $934,956	13,200 Added 231.58%	18,900 $1.29 Million
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $10.4 Million - $18.7 Million	-251,800 Reduced 97.79%	5,700 $240,000
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $14 Million - $18.4 Million	249,000 Added 2929.41%	257,500 $17.8 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $2.04 Million - $2.61 Million	-34,500 Reduced 80.23%	8,500 $628,000
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $413,688 - $627,330	6,600 Added 18.13%	43,000 $4.04 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $1.72 Million - $2.58 Million	36,400 New	36,400 $2.47 Million
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $209,181 - $298,452	2,100 New	2,100 $278,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.